Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)
-
Catalog numberGEN608822
-
PricePlease ask
-
Size100ug
-
-
Also known asEpilepsy, Progressive Myoclonus Type 2A
-
Other namesEpilepsy, progressive myoclonus type 2A, Lafora disease (laforin); Laforin; laforin; LAFPTPase; lafora PTPase; OTTHUMP00000017360; OTTHUMP00000017361; epilepsy, progressive myoclonus type 2, Lafora disease (laforin); epilepsy, progressive myoclonus type 2A, Lafora disease (laforin); Lafora PTPase
-
CategoryAntibodies
-
SubcategoryMnoclonal antibodies
-
Gene nameEPM2A; EPM2A; EPM2; MELF; N/A
-
Gene name synonimsEPM2A; EPM2A; EPM2; MELF; N/A
-
Other gene namesEPM2A; EPM2A; EPM2; MELF; N/A
-
ClonalityMonoclonal
-
Immunoglobulin isotypeIgG2b
-
Clone9H116
-
Host organismMouse (Mus musculus)
-
Source organismHuman (Homo sapiens)
-
Species reactivityHuman (Homo sapiens); Due to limited knowledge and inability for testing each and every species, the reactivity of the antibody may extend to other species which are not listed hereby.
-
Specificity and cross reactivityDetects endogenous human Laforin at 38kD using Western blot. ; Since it is not possible to test each and every species our knowledge on the corss reactivity of the antibodies is limited. This particular antibody might cross react with speacies outside of the listed ones.
-
Purification methodAffinity Purified by Protein G immunoaffinity chromatography.
-
Form AppearanceSupplied as lyophilized from a 0.2um sterile-filtered solution in PBS with 5% trehalose. Reconstitute in PBS containing 0.02% sodium azide.
-
ConcentrationN/A
-
Storage and shippingLyophilized powder may be stored the antibody should be stored at -20 degrees Celsius.. Stable for 12 months the antibody should be stored at -20 degrees Celsius.. Reconstitute by adding sterile 40-50% glycerol, aliquot and For optimal long term storage, the antibody should be kept at -20 degrees Celsius. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
-
Tested applicationsWestern Blot (WB)
-
Gene target
-
Gene symbolEPM2AIP1, EPM2A, EPM2A-DT
-
Short nameEpilepsy, Progressive Myoclonus 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)
-
Alternative nameAnti-Epilepsy, Progressive Myoclonus Type 2A (Lafora Disease, EPM2A, Laforin, LD, LDE, EPM2, MELF, LAFPTPase, FLJ11207, KIAA0766)
-
Gene info
-
Identity
-
Gene
-
Long gene nameEPM2A interacting protein 1
-
Synonyms gene name
- EPM2A (laforin) interacting protein 1
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year2003-03-26
-
Entrez gene record
-
RefSeq identity
-
VEGA ID
Gene info
-
Identity
-
Gene
-
Long gene nameEPM2A glucan phosphatase, laforin
-
Synonyms gene name
- epilepsy, progressive myoclonus type 2, Lafora disease (laforin)
- epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
- EPM2A, laforin glucan phosphatase
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1998-10-01
-
Entrez gene record
-
Pubmed identfication
-
Classification
- Atypical dual specificity phosphatases
-
VEGA ID
Gene info
-
Identity
-
Gene
-
Long gene nameEPM2A divergent transcript
-
Synonyms gene
-
Synonyms gene name
- FBXO30 divergent transcript
-
Locus
-
Discovery year2020-01-17
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- Divergent transcripts